Navigation Links
Certain Antidepressants Ease Fibromyalgia Symptoms
Date:1/13/2009

Tricyclic medications helped with pain, fatigue and depression, study shows

TUESDAY, Jan. 13 (HealthDay News) -- Antidepressants may help people living with the chronic pain of fibromyalgia experience fewer symptoms and improve their quality of life, new research shows.

The study, lead by Dr. Winfried Hauser, of Klinikum Saarbrucken in Germany, found that fibromyalgia patients had less pain, fatigue and depression while on certain antidepressants.

Tricyclic and tetracyclic antidepressants helped the most to reduce pain, fatigue and sleep disturbances, according to the report published in the Jan. 14 issue of the Journal of the American Medical Association. Serotonin and noradrenaline reuptake inhibitors helped with those three symptoms but to a much lesser extent, while selective serotonin reuptake inhibitors and monoamine oxidase inhibitors helped lessen pain some.

Fibromyalgia affects up to nearly 6 percent of people in North America and Europe, carrying with it high direct and indirect disease-related costs.

"Since evidence for a long-term effect of antidepressants in [fibromyalgia] is still lacking, their effects should be re-evaluated at regular intervals to determine whether benefits outweigh adverse effects," the authors wrote in a news release from the journal. "The identification of patient characteristics associated with positive and negative therapeutic outcomes are needed to better target antidepressant therapy for [fibromyalgia]."

More information

The National Fibromyalgia Association has more about fibromyalgia.



-- Kevin McKeever



SOURCE: JAMA, news release, Jan. 13, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Use of certain lipid measures not more effective in predicting coronary heart disease
2. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
3. MU researchers studying model to learn why certain cancers become resistant to drugs
4. New All-Natural Dietary Supplement Made from Muscadine Grape Skins Helps Inhibit Growth of Certain Cancers
5. Effectiveness of most PTSD therapies is uncertain
6. Value of Most Post-Traumatic Stress Treatments Uncertain
7. Certain Seizure Patients Need Emergency CT Scan
8. Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories
9. Certain Cholesterol Drugs Show Their Limits
10. ADHD Delays Growth of Certain Brain Areas
11. Stress hormone may hasten the progression of certain blood cancers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Certain Antidepressants Ease Fibromyalgia Symptoms 
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology: